Cooperation Wilhelmina Children’s Hospital and Princess Máxima Center: young adults in paediatric ICU

Date:
WKZ, afdeling, ziekenhuis

After careful coordination, the Wilhelmina Children’s Hospital and the Princess Máxima Center have decided that young adults from the Princess Máxima Center will, in principle until the age of 21, be treated in the paediatric ICU at the Wilhelmina Children’s Hospital.

In most cases, young adults from the age of 18 go to the Intensive Care for adults but to give continuity to paediatric cancer treatment, this will be different for children with cancer from now on. Wilhelmina Children’s Hospital, UMC Utrecht and the Princess Máxima Centre are committed to providing optimal cancer care for children, adolescents and young adults.

Louis Bont, head of the Children’s Division at UMC Utrecht/WKZ: ‘At the Wilhelmina Children’s Hospital and UMC Utrecht, everything revolves around life-course care; from before birth into adulthood. Here, special attention is paid to the transition from childhood to young adulthood. And especially when dealing with the consequences of cancer.’

Wouter Kollen, Clinical Director Quality of Life at the Princess Máxima Centre, says: ‘With this agreement, we ensure that the accumulated expertise in the ICU around children with cancer, is maximised and that the support of our children and young adults is also as optimal as possible.’ Of course, this takes into account the young adult’s individual needs and available capacity. This concerns vulnerable patients and their loved ones in specific situations where customization and care are always of great importance.

Young adults

The period of young adulthood is a special phase in everyone’s life with many challenges. In general terms, paediatricians care for chronically ill children until the age of 18. After that, they transition to adult care. This transition is called transition care and requires careful preparation and supervision. This ensures that young adults maintain confidence in care, remain compliant and that the course of the disease and follow-up are not adversely affected. By providing intensive care in the paediatric ICU to young adults up to 21 years of age, another step has been taken in improving care for children with cancer in the Netherlands.

Registration for Utrecht Science Week 2026 is now open: the knowledge festival at Utrecht Science Park

From Friday 25 September to Sunday 4 October, the sixth edition of Utrecht Science Week will take place. Utrecht Science Park will open its doors to everyone interested in (applied) science and innovation in the fields of life sciences, health, and sustainability.

The first programme elements have now been announced and registration is open. Many more events and activities will be added to the programme in the coming weeks.

New artificial heart implanted for the first time in Europe

Earlier this month at UMC Utrecht, a patient with advanced heart failure became the first person in Europe to receive a BrioVAD ventricular assist device. The new system is being evaluated in a European study and may offer advantages over the existing ventricular assist device. For UMC Utrecht, the implantation marks a new milestone in a long history of innovation in the field of mechanical circulatory support.

Successful first edition of Utrecht Life Sciences TechConnect

On 4 June 2026, researchers, technology experts, facility staff and innovation partners from across the Utrecht Life Sciences community gathered at Utrecht Science Park for the first edition of Utrecht Life Sciences TechConnect. The new annual event was created to strengthen connections between researchers and technology facilities, showcase advanced research technologies, and stimulate collaboration across disciplines.

Opening Utrecht Science Week with keynote by Juliette Legler on the hidden influence of environmental chemicals

On Friday, September 25, the annual science festival ‘Utrecht Science Week’ kicks off once again at Utrecht Science Park. We are pleased to announce that this year, Prof. Dr. Ir. Juliette Legler will deliver the Utrecht Science Lecture. Juliette Legler is Professor of Toxicology at the Faculty of Veterinary Medicine at Utrecht University and leads the ‘One Health Toxicology’ group at the Institute for Risk Assessment Sciences (IRAS).